Prime Medicine, Inc. (PRME)
NASDAQ·Healthcare·Biotechnology
$3.12
+8.36%
Mkt Cap $501.21M
Analyst Ratings
No recent rating data.
Price Target (4 analysts)
$17.25
Range $12.00 – $23.00
Implied Upside
+453.8%
Consensus $17.25 vs current $3.12
NASDAQ·Healthcare·Biotechnology
$3.12
+8.36%
Mkt Cap $501.21M
No recent rating data.
Price Target (4 analysts)
$17.25
Range $12.00 – $23.00
+453.8%
Consensus $17.25 vs current $3.12